MHRA Drug Safety Update October 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 3 October 2021) has been published and includes articles on:

  • Tofacitinib (Xeljanz▼): new measures to minimise risk of major adverse cardiovascular events and malignancies
  • Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication
  • MedSafetyWeek November 2021: support the safety of vaccines
  • COVID-19 vaccines: updates for October 2021
  • Letters and medicine recalls sent to healthcare professionals in September 2021

To see the latest MHRA Drug Safety Updates in full, visit the website

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here